1.
AIDS
; 17(14): 2129-31, 2003 Sep 26.
Article
in English
| MEDLINE
| ID: mdl-14502020
Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Acquired Immunodeficiency Syndrome/drug therapy , Antiretroviral Therapy, Highly Active/methods , Tuberculosis/epidemiology , Adult , CD4 Lymphocyte Count , Humans , Incidence , Mycobacterium avium-intracellulare Infection/epidemiology , Prospective Studies , Thailand/epidemiology
2.
J Acquir Immune Defic Syndr
; 33(1): 118-9, 2003 May 01.
Article
in English
| MEDLINE
| ID: mdl-12792366
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , Meningitis, Cryptococcal/complications , Oxazines/therapeutic use , Adult , Alkynes , Anti-HIV Agents/adverse effects , Benzoxazines , CD4 Lymphocyte Count , Cryptococcus neoformans , Cyclopropanes , Female , HIV/genetics , HIV/isolation & purification , Humans , Male , Meningitis, Cryptococcal/microbiology , Oxazines/adverse effects , RNA, Viral/blood , Thailand , Time Factors
3.
Clin Infect Dis
; 36(10): 1329-31, 2003 May 15.
Article
in English
| MEDLINE
| ID: mdl-12746781
ABSTRACT
A prospective, multicenter, randomized study was conducted with human immunodeficiency virus (HIV)-infected patients who were successfully treated for acute cryptococcal meningitis, were receiving secondary prophylaxis, and were naive for antiretroviral therapy. Patients were randomized to continue or discontinue secondary prophylaxis when the CD4 cell count had increased to >100 cells/microL and an undetectable HIV RNA level had been sustained for 3 months. At a median of 48 weeks after randomization, there were no episodes of cryptococcal meningitis in either group.